Elevation Oncology is ditching its sole clinical-stage asset in the wake of disappointing phase 1 data, leading the ...

Elevation Oncology shares halted from trading in premarket trading Thursday after it said it will launch strategic options process and lay off the majority of its staff to extend its cash runway.

The lay offs will start in May and continue through ... CX-904 as a way to save cash and focus on its lead antibody-drug conjugate. Story ...

Melanie Hawkins’ life revolves around the Minneapolis American Indian Center. Every day she scours the building as its lead ...

You can help them to understand past and future tenses by practising talking with them about things that have happened and will happen later on. Perhaps you could discuss the things that happened ...

Soon-to-be medical school graduates received 877 more primary care position offers in the 2025 Main Residency Match compared with the previous year, according to the National Resident Matching ...

19 March 2025 UK biotech Oxford BioTherapeutics (OBT), a clinical stage oncology company with a pipeline of immuno-oncology (I-O) and antibody drug conjugate (ADC)-based therapies, today announced a ...